We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Amneal Tells Fed Circ. Endo Played With Numbers In Patent

Law360, New York (June 14, 2016, 11:13 PM EDT) -- Amneal Pharmaceuticals LLC renewed its push Monday to persuade the Federal Circuit to reverse a Patent Trial and Appeal Board ruling that prior art didn’t make Endo Pharmaceuticals Inc.’s patents for...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.